ALDA develops powerful sanitiser
ALDA Pharmaceuticals, of Vancouver, Canada, has developed a powerful, safe hand sanitiser based on its patent-pending T(3)6 technology.
It has been proven to completely kill all 57 bacteria, viruses and fungi on which it has been tested, including polio and TB, the two benchmark micro-organisms known to be the most resistant to disinfectants.
The ability to kill polio and TB means that the new hand sanitiser is also acknowledged to be effective against all bacteria and viruses including avian influenza, SARS, Norwalk Virus, HIV, Legionella and hepatitis.
Dr Terrance Owen, president and ceo of ALDA Pharmaceuticals, said: "People are becoming increasingly aware that many infectious diseases are passed on through direct hand contact. ALDA is excited to enter this marketplace with a technology that is effective against so many of these easily transmittable diseases."
ALDA's therapeutic subsidiary, Sirona Therapeutics, is seeking regulatory approval and commercialisation in accordance with its agreement with ALDA, after which the product will be available in US, Canadian, Asian and European markets.